We are live on ! Find out more
CVSC

C.V. Starr & Co Portfolio holdings

AUM $192M
1-Year Est. Return 35.69%
This Fund
S&P 500
This Quarter Est. Return
-25.86%
1 Year Est. Return
+35.69%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$21M
AUM Growth
-$8.12M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
2
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 83.89%
2 Consumer Discretionary 16.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CELU icon
1
Celularity
CELU
$21.7M
$17.6M 83.89%
764,069
AMZN icon
2
Amazon
AMZN
$2.5T
$3.39M 16.11%
30,000

Similar funds

C.V. Starr & Co's Q3 2022 Portfolio in Review

As of Q3 2022, C.V. Starr & Co held 2 positions worth $21M, down 28% from $29.2M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2022: portfolio turnover was 0%. C.V. Starr & Co opened no new positions and made no exits, leaving the 2-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 84% of assets, down from 89% a quarter earlier, followed by Consumer Discretionary.

  • C.V. Starr & Co's ten largest holdings make up 100% of its $21M portfolio in Q3 2022.
  • C.V. Starr & Co opened 0 new positions and closed 0 in Q3 2022.
  • C.V. Starr & Co's portfolio value fell 28% quarter-over-quarter to $21M.

Based on C.V. Starr & Co's 13F filing for Q3 2022, filed 31 Oct 2022.